Surgery Partners Inc (SGRY) Shares Sold by Ameriprise Financial Inc.
Ameriprise Financial Inc. reduced its position in Surgery Partners Inc (NASDAQ:SGRY) by 6.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 213,840 shares of the company’s stock after selling 15,735 shares during the quarter. Ameriprise Financial Inc.’s holdings in Surgery Partners were worth $2,213,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Round Table Services LLC bought a new position in shares of Surgery Partners during the third quarter valued at approximately $138,000. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Surgery Partners by 16.7% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 13,716 shares of the company’s stock valued at $312,000 after purchasing an additional 1,963 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in shares of Surgery Partners during the second quarter valued at approximately $306,000. JHL Capital Group LLC bought a new position in shares of Surgery Partners during the second quarter valued at approximately $2,275,000. Finally, State Street Corp grew its holdings in shares of Surgery Partners by 7.7% during the second quarter. State Street Corp now owns 354,115 shares of the company’s stock valued at $8,059,000 after purchasing an additional 25,446 shares during the last quarter. 94.16% of the stock is owned by hedge funds and other institutional investors.
Surgery Partners Inc (NASDAQ SGRY) opened at $12.65 on Friday. The company has a current ratio of 2.09, a quick ratio of 1.92 and a debt-to-equity ratio of 1.56. The stock has a market capitalization of $604.98 and a P/E ratio of -140.56. Surgery Partners Inc has a 52-week low of $7.10 and a 52-week high of $24.05.
SGRY has been the subject of several recent research reports. Royal Bank of Canada reaffirmed a “buy” rating and set a $18.00 target price on shares of Surgery Partners in a report on Sunday, November 12th. Jefferies Group lowered their target price on Surgery Partners from $16.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 1st. Bank of America lowered their target price on Surgery Partners from $23.00 to $19.00 and set a “buy” rating for the company in a report on Monday, October 9th. BidaskClub raised Surgery Partners from a “sell” rating to a “hold” rating in a report on Wednesday, December 27th. Finally, KeyCorp reaffirmed a “hold” rating on shares of Surgery Partners in a report on Tuesday, October 31st. Three analysts have rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $18.57.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners Inc (NASDAQ:SGRY).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.